GO:0060736 prostate gland growth: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060736 (prostate gland growth) describes the increase in size or mass of the prostate gland that drives its progression from formation to a mature state.
• Prostate growth is controlled by a balance of endocrine signals (androgens), paracrine growth factors such as FGFs, and epithelial-stromal interactions.
• The autonomic nervous system directly facilitates growth of the rat prostate gland, linking neural inputs to organ size.
• Zonal growth patterns of the prostate are affected by age and body mass index, showing that growth is not uniform across the gland.
• Inflammation and TNF-alpha signaling can influence prostate growth, and TNF-alpha inhibitor therapy has been studied for its effect on gland growth.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of genes implicated in prostate gland growth.
Description
GO:0060736, prostate gland growth, is a biological process defined as the increase in size or mass of the prostate gland where the increase in size or mass has the specific outcome of the progression of the gland, from its formation to its mature state. This term captures the developmental and homeostatic expansion of the prostate, an organ whose growth is regulated by a complex interplay of hormonal, neural, and local growth factor signals. Understanding this process is essential because perturbations in prostate growth underlie benign prostatic hyperplasia and contribute to prostate cancer progression. The prostate is a male accessory sex gland whose growth depends on androgens and on reciprocal signaling between epithelium and stroma. Fibroblast growth factors (FGFs) and their receptors are central regulators of prostate growth and physiopathology, acting through autocrine and paracrine loops. In addition, the autonomic nervous system provides trophic input that facilitates prostate growth in rodent models. More recent work has shown that zonal growth patterns of the prostate are affected by age and body mass index, indicating that growth is spatially and metabolically modulated. Inflammation, particularly TNF-alpha signaling, has also been linked to prostate growth, and TNF-alpha inhibitor therapy has been evaluated for its effect on gland growth. For researchers, GO:0060736 provides a precise ontological handle for annotating genes, pathways, and experimental models that drive or restrain prostate enlargement.
prostate gland growth At A Glance
| GO ID | GO:0060736 |
|---|---|
| GO term | prostate gland growth |
| Ontology | biological_process |
| Synonym | none |
| Definition | The increase in size or mass of the prostate gland where the increase in size or mass has the specific outcome of the progression of the gland, from its formation to its mature state. |
| Major function | Drives maturation and enlargement of the prostate gland through hormonal, neural, and growth factor signaling. |
| Key regulators | Androgens, FGF/FGFR signaling, autonomic nervous system, epithelial-stromal interactions. |
| Associated conditions | Benign prostatic hyperplasia, prostate cancer, inflammation-related growth changes. |
| Research models | Rodent prostate growth models, CRISPR knockout/knock-in cell and animal models, zonal imaging studies. |
What Is GO:0060736?
In our own words, GO:0060736 (prostate gland growth) refers to the biological process by which the prostate gland increases in size or mass, specifically resulting in the gland's progression from its initial formation to a mature state. This definition emphasizes that growth is not merely an increase in volume but is tied to the developmental maturation of the organ. The process encompasses cellular proliferation, hypertrophy, extracellular matrix remodeling, and stromal-epithelial interactions that collectively expand the gland. It is regulated by endocrine factors such as androgens, paracrine growth factors including FGFs, and neural inputs. The term is distinct from pathological prostate growth, although the same mechanisms can be co-opted in disease.
Why Is prostate gland growth Important in Cell Biology?
Prostate gland growth is fundamental to male reproductive biology and is directly implicated in the most common prostate diseases. The same signaling pathways that drive normal maturation, such as FGF/FGFR and androgen signaling, are frequently dysregulated in benign prostatic hyperplasia and prostate cancer. Understanding the mechanisms of prostate growth therefore provides a foundation for identifying therapeutic targets and biomarkers. Moreover, the discovery that autonomic innervation facilitates prostate growth highlights neuro-organ interactions that may be exploited or blocked in disease. Age and body mass index influence zonal growth patterns, linking metabolic and demographic factors to prostate enlargement. Finally, inflammation and TNF-alpha signaling have emerged as modulators of prostate growth, suggesting that immunomodulatory therapies could affect gland size.
• Provides a mechanistic basis for benign prostatic hyperplasia, a major cause of lower urinary tract symptoms.
• Links androgen and FGF signaling to prostate cancer progression.
• Highlights neural control of organ growth via the autonomic nervous system.
• Shows that growth is zonally heterogeneous and influenced by age and BMI.
• Implicates inflammation and TNF-alpha in prostate growth regulation.
• Supports development of CRISPR models to test causal genes in prostate growth.
• Guides research on epithelial-stromal crosstalk in development and disease.
• Offers targets for pharmacological modulation of prostate size.
• Enables comparative studies of normal versus pathological growth.
• Informs regenerative and developmental biology of male accessory glands.
What Happens During prostate gland growth?
Initiation and hormonal priming
In simple terms: Androgens and other hormones give the prostate the initial signal to start growing.
Prostate gland growth begins with hormonal priming, primarily by androgens, which set the stage for subsequent expansion. Regulation of prostate growth involves a complex interplay of endocrine and paracrine factors. Androgens act on the stroma and epithelium to initiate growth programs, and this process is tightly linked to the developmental maturation of the gland. The autonomic nervous system also contributes to the initiation of growth, as denervation studies in rats show that intact innervation is required for normal prostate growth.
Paracrine growth factor signaling
In simple terms: Local growth factors act as messengers between cells to drive prostate enlargement.
Fibroblast growth factors (FGFs) and their receptors are key paracrine regulators of prostate growth. The FGF/FGFR system is central to the physiopathology of the prostate gland, controlling proliferation, differentiation, and stromal-epithelial interactions. Regulation of prostate growth by FGFs has been extensively documented, with FGFs acting as mitogens for prostate cells. Growth factors and epithelial-stromal interactions are also critical in prostate cancer development, underscoring the importance of these signaling axes.
Epithelial-stromal interactions
In simple terms: The two main cell layers of the prostate talk to each other to coordinate growth.
Prostate growth depends on reciprocal signaling between epithelial and stromal compartments. Growth factors and epithelial-stromal interactions are fundamental to prostate development and cancer. Stromal cells produce growth factors that act on epithelial cells, and epithelial cells in turn signal back to the stroma, creating a feedback loop that drives gland expansion. This crosstalk is essential for the progression of the gland from formation to mature state.
Neural regulation of growth
In simple terms: Nerves supplying the prostate release signals that help it grow.
The autonomic nervous system facilitates prostate growth. Studies in rats demonstrate that growth of the prostate gland is facilitated by the autonomic nervous system, and prostate innervation provides trophic support. Denervation experiments show reduced prostate growth, indicating that neural inputs are not merely permissive but actively promote growth. This neuro-organ interaction represents a distinct layer of regulation beyond hormones and growth factors.
Zonal and metabolic modulation
In simple terms: Different parts of the prostate grow at different rates depending on age and body weight.
Prostate growth is not uniform across the gland. Zonal growth patterns of the prostate are affected by age and body mass index, with different zones exhibiting distinct growth trajectories. This heterogeneity has implications for understanding benign prostatic hyperplasia, which often arises in specific zones. Metabolic factors such as BMI may influence growth through systemic signals, adding another dimension to the regulation of prostate size.
Inflammatory modulation
In simple terms: Inflammation can change how the prostate grows, and blocking certain inflammatory signals may affect gland size.
Inflammation and cytokines such as TNF-alpha modulate prostate growth. A clinical study evaluated the effect of TNF-alpha inhibitor therapy on growth of the prostate gland, highlighting a link between inflammatory signaling and prostate size. This suggests that immune pathways can intersect with classical growth factor and hormonal pathways to influence prostate growth.
Key Genes Involved in GO:0060736 prostate gland growth
The following genes and proteins are experimentally implicated in prostate gland growth and its regulation, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FGF2 | Fibroblast growth factor 2; promotes prostate cell proliferation | Key paracrine mitogen in prostate growth and cancer |
| FGF7 | Keratinocyte growth factor; stimulates epithelial proliferation | Mediates stromal-epithelial crosstalk in prostate |
| FGF8 | Androgen-regulated growth factor | Implicated in prostate cancer progression and growth |
| FGFR1 | FGF receptor 1; mediates FGF signaling | Central to FGF-driven prostate growth |
| FGFR2 | FGF receptor 2; epithelial FGF signaling | Regulates prostate epithelial proliferation |
| AR | Androgen receptor; mediates androgen action | Master regulator of prostate growth and maturation |
| TNF | Tumor necrosis factor; inflammatory cytokine | Modulates prostate growth; target of inhibitor therapy |
| TGFB1 | Transforming growth factor beta 1; regulates growth inhibition and stroma | Dual role in prostate growth and cancer |
| IGF1 | Insulin-like growth factor 1; promotes growth | Systemic growth factor influencing prostate size |
| EGF | Epidermal growth factor; mitogenic for prostate cells | Contributes to prostate epithelial proliferation |
| VEGFA | Vascular endothelial growth factor A; angiogenesis | Supports prostate growth via vascular supply |
| MMP2 | Matrix metalloproteinase 2; ECM remodeling | Facilitates tissue expansion during growth |
| MMP9 | Matrix metalloproteinase 9; ECM remodeling | Associated with prostate growth and cancer |
| SYP | Synaptophysin; neural marker | Used to assess prostate innervation |
| TH | Tyrosine hydroxylase; sympathetic marker | Marks autonomic innervation of prostate |
| CHAT | Choline acetyltransferase; parasympathetic marker | Marks cholinergic innervation of prostate |
| NKX3-1 | Homeobox transcription factor; prostate development | Regulates prostate epithelial growth and differentiation |
| FOXA1 | Forkhead box A1; transcription factor | Involved in prostate epithelial growth and cancer |
How Is prostate gland growth Regulated?
Prostate gland growth is regulated by a multilayered network. Androgens, acting through the androgen receptor, provide the primary endocrine drive. Paracrine FGF/FGFR signaling is a major local regulator, with FGFs controlling proliferation and differentiation of prostate cells. The autonomic nervous system facilitates growth, as shown by denervation studies in rats. Epithelial-stromal interactions integrate these signals, with growth factors and extracellular matrix components mediating crosstalk. Age and body mass index further modulate zonal growth patterns. Inflammatory cytokines such as TNF-alpha can also influence prostate growth, and TNF-alpha inhibitor therapy has been studied for its effects on gland size. Together, these regulatory inputs determine the overall growth trajectory of the prostate.
prostate gland growth and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FGF2 | BPH and prostate cancer | Knockout or overexpression in prostate cell lines and mouse models |
| FGFR1 | Prostate cancer progression | Point mutation to abrogate kinase activity; knock-in models |
| AR | Prostate cancer and androgen insensitivity | Point mutation knock-in mice; CRISPR knockout in LNCaP cells |
| TNF | Inflammation-associated prostate growth | TNF knockout mice; TNF inhibitor treatment models |
| NKX3-1 | Prostate development and cancer | Conditional knockout mouse models |
Benign prostatic hyperplasia (BPH)
BPH is characterized by non-malignant enlargement of the prostate, often arising from dysregulated growth in specific zones. The mechanisms of prostate growth, including androgen and FGF signaling, are directly implicated in BPH pathogenesis. Zonal growth patterns affected by age and BMI may explain why BPH predominantly affects certain regions of the gland. Understanding normal prostate growth provides a framework for identifying therapeutic targets to limit pathological enlargement.
Prostate cancer
Prostate cancer is driven by many of the same growth factor pathways that regulate normal prostate growth. FGF/FGFR signaling is frequently dysregulated in prostate cancer, promoting proliferation and survival. Growth factors and epithelial-stromal interactions are critical in prostate cancer development, and targeting these pathways is an active area of research. Androgen receptor signaling remains a cornerstone of prostate cancer therapy, underscoring the link between growth regulation and malignancy.
Inflammation-associated prostate growth
Chronic inflammation has been linked to prostate growth and disease. TNF-alpha, a key inflammatory cytokine, can modulate prostate growth, and TNF-alpha inhibitor therapy has been evaluated for its effect on gland growth. This suggests that anti-inflammatory strategies may influence prostate size and potentially alter disease progression.
From prostate gland growth-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X drive prostate epithelial proliferation? | CRISPR knockout of gene X in prostate organoids or cell lines |
| Does a specific point mutation in FGFR1 alter prostate growth? | Point-mutation knock-in in mouse prostate or cell lines |
| Does overexpression of FGF2 enlarge the prostate? | Transgenic overexpression or viral delivery in mouse prostate |
| What is the role of AR in prostate maturation? | Conditional AR knockout or point-mutation knock-in mice |
| How does autonomic innervation affect prostate growth? | Chemical or surgical denervation in rodent models |
| How do age and BMI affect zonal prostate growth? | Longitudinal imaging in human cohorts or aged rodent models |
How to Study the prostate gland growth Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Rodent prostate weight and histology | Organ size and cellular composition | Assessing growth after hormonal or neural manipulation |
| Organoid proliferation assays | Epithelial cell proliferation | Testing FGF or androgen effects in vitro |
| Immunohistochemistry | Protein expression and localization | Detecting AR, FGFs, neural markers in prostate tissue |
| RNA sequencing | Transcriptomic changes during growth | Identifying growth-associated gene signatures |
| MRI and ultrasound | Prostate volume and zonal dimensions | Clinical and preclinical assessment of growth patterns |
| CRISPR knockout screens | Gene essentiality for prostate cell growth | Discovering novel regulators of prostate growth |
| Cytokine assays | TNF-alpha and other inflammatory mediators | Linking inflammation to prostate growth |
Rodent prostate growth models
Rodent models, particularly rats and mice, are widely used to study prostate growth. Denervation experiments in rats have demonstrated that the autonomic nervous system facilitates prostate growth. Hormonal manipulation, such as castration and androgen replacement, is a classic approach to study androgen-dependent growth. These models allow direct measurement of prostate size and histological analysis.
Cell and organoid culture
Prostate epithelial and stromal cell lines, as well as organoids, enable mechanistic studies of growth factor signaling. FGF/FGFR signaling can be manipulated in vitro to assess effects on proliferation and differentiation. Epithelial-stromal co-cultures model the reciprocal interactions that drive prostate growth. CRISPR editing in these systems allows causal testing of candidate genes.
Imaging and zonal analysis
Imaging techniques, including MRI and histology, are used to assess prostate volume and zonal growth patterns. Studies have shown that zonal growth is affected by age and body mass index, requiring careful anatomical segmentation. Such imaging can be combined with molecular markers to link growth to specific signaling pathways.
Molecular and genomic profiling
RNA sequencing, proteomics, and immunohistochemistry are used to profile gene expression during prostate growth. Growth factors and their receptors, such as FGFs and FGFRs, are commonly assessed. Neural markers like tyrosine hydroxylase and choline acetyltransferase help quantify innervation. Inflammatory markers such as TNF-alpha can be measured to assess their role in growth.
How CRISPR Can Be Used to Study GO:0060736 prostate gland growth
Knockout
CRISPR knockout is used to delete candidate genes in prostate cell lines, organoids, or mouse models to test their requirement for prostate growth. For example, knocking out FGFR1 or FGF2 can reveal whether FGF signaling is essential for proliferation. Knockout of AR in prostate epithelium helps dissect androgen-dependent growth. High-throughput knockout screens can identify novel growth regulators.
Point Mutation
Point mutations can be introduced to model specific amino acid changes that alter protein function, such as kinase-dead FGFR1 or ligand-binding mutants of AR. These models are valuable for understanding how subtle genetic changes affect prostate growth. Point-mutation knock-in mice can mimic human variants associated with prostate disease.
Knock-in
Knock-in strategies allow precise insertion of reporters, tags, or human disease alleles. Tagged knock-in of growth factor genes enables tracking of protein expression and localization during prostate growth. Knock-in of mutant AR or FGFR alleles can model familial or somatic mutations linked to prostate cancer.
Overexpression
Overexpression models, often achieved via transgenic or viral delivery, test whether increased levels of a growth factor drive prostate enlargement. Overexpression of FGF2 or FGF8 in the prostate can promote hyperplasia and tumorigenesis. These models complement knockout studies by demonstrating sufficiency.
How EDITGENE Supports prostate gland growth Research
Researchers studying prostate gland growth-related genes often need to determine whether a candidate gene is causally involved in driving or restraining prostate enlargement. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies, from knockout to precise point mutations, knock-ins, and overexpression, as well as library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for prostate gland growth research.
Frequently Asked Questions About prostate gland growth
What is GO:0060736?
GO:0060736 is the Gene Ontology term for prostate gland growth, defined as the increase in size or mass of the prostate gland that results in its progression from formation to a mature state.
What genes are involved in prostate gland growth?
Key genes include FGF2, FGF7, FGF8, FGFR1, FGFR2, AR, TNF, TGFB1, IGF1, EGF, and NKX3-1, among others.
How is prostate gland growth regulated?
It is regulated by androgens, FGF/FGFR signaling, autonomic innervation, epithelial-stromal interactions, and inflammatory cytokines such as TNF-alpha.
What is the role of the autonomic nervous system in prostate growth?
The autonomic nervous system facilitates prostate growth, as denervation in rats reduces gland growth, indicating a trophic neural input.
Does body mass index affect prostate growth?
Yes, zonal growth patterns of the prostate are affected by age and body mass index, suggesting metabolic modulation of growth.
Can TNF-alpha inhibitors affect prostate growth?
TNF-alpha inhibitor therapy has been studied for its effect on growth of the prostate gland, indicating a link between inflammation and prostate size.
What research models are used to study prostate gland growth?
Rodent models, prostate cell lines, organoids, and CRISPR-edited models are commonly used to study prostate growth mechanisms.
How can CRISPR be used to study prostate growth genes?
CRISPR knockout, point mutation, knock-in, and overexpression can test the causal role of genes like FGFR1, AR, and FGF2 in prostate growth.
What diseases are linked to prostate gland growth?
Benign prostatic hyperplasia, prostate cancer, and inflammation-associated prostate enlargement are linked to dysregulated prostate growth.
Why is prostate gland growth important for cancer research?
Many growth factor pathways that drive normal prostate growth, such as FGF/FGFR and AR signaling, are dysregulated in prostate cancer, making growth mechanisms relevant to cancer research.
Conclusion
GO:0060736 (prostate gland growth) is a biologically and clinically significant process that integrates hormonal, neural, paracrine, and inflammatory signals to control the size and maturation of the prostate. Understanding its mechanisms is essential for addressing benign prostatic hyperplasia, prostate cancer, and inflammation-related growth changes. The availability of CRISPR-based models and advanced imaging and molecular profiling tools now allows researchers to dissect the causal roles of individual genes in prostate growth with unprecedented precision. Continued research in this area promises to yield new therapeutic strategies for prostate diseases.
References
- 1. Al-Faouri R et al.. 2024. Effect of TNF-α Inhibitor Therapy on Growth of the Prostate Gland.. Eur Urol Focus 10(4):641-647 PMID: 39492303
- 2. McVary KT et al.. 1998. Prostate innervation.. Prostate Suppl 8:2-13 PMID: 9690657
- 3. McVary KT et al.. 1994. Growth of the rat prostate gland is facilitated by the autonomic nervous system.. Biol Reprod 51(1):99-107 PMID: 7918880
- 4. Giacomini A et al.. 2021. The FGF/FGFR system in the physiopathology of the prostate gland.. Physiol Rev 101(2):569-610 PMID: 32730114
- 5. Sharkey C et al.. 2022. Zonal Growth Pattern of the Prostate Is Affected by Age and Body Mass Index.. J Urol 207(4):876-884 PMID: 34854747
- 6. Story MT. 1995. Regulation of prostate growth by fibroblast growth factors.. World J Urol 13(5):297-305 PMID: 8581001
- 7. Davies P et al.. 1991. Regulation of prostate growth.. J Endocrinol 131(1):5-17 PMID: 1744559
- 8. Wong YC et al.. 2000. Growth factors and epithelial-stromal interactions in prostate cancer development.. Int Rev Cytol 199:65-116 PMID: 10874577
